Discontinued — last reported Q4 '23
Natera, Inc. Proceeds From Issuance Of Common Stock Net remained flat by 0.0% to $58.86M in Q4 2023 compared to the prior quarter. Year-over-year, this metric declined by 45.6%, from $108.30M to $58.86M.
An increase indicates successful capital raising or high employee participation in stock plans, while a decrease may suggest reduced reliance on equity financing.
This represents the total cash inflows received from the issuance of common equity to investors or employees. It reflect...
Common in growth-stage biotech companies; peers often show periodic spikes during secondary offerings.
financing_proceeds_from_issuance_of_common_stock_net_b01dca| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $8.00K | $108.30M | $108.30M | $108.30M | $108.30M | $58.86M | $58.86M | $58.86M | $58.86M |
| QoQ Change | — | >999% | +0.0% | +0.0% | +0.0% | -45.6% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | >999% | -45.6% | -45.6% | -45.6% | -45.6% |